×
About 1,103 results

ALLMedicine Injecting Drug Use Center

Research & Reviews  517 results

Low hepatitis C virus reinfection rate despite ongoing risk following universal access ...
https://doi.org/10.1097/QAD.0000000000002562
AIDS (London, England); Hosseini-Hooshyar S, Martinello M et. al.

Jun 26th, 2020 - To evaluate changes in injecting and sexual risk behaviours, and hepatitis C virus (HCV) reinfection incidence among people with HIV/HCV coinfection following unrestricted access to direct-acting antiviral therapy in Australia. Prospective observa...

Anti-envelope antibody responses in highly exposed seronegative individuals may be asso...
https://doi.org/10.1111/jvh.13339
Journal of Viral Hepatitis REFERENCES; Mina M, Underwood A et. al.

Jun 4th, 2020 - In rare cases, individuals with a history of long-term injecting drug use remain seronegative and aviraemic, despite prolonged and likely repeated exposure to Hepatitis C virus (HCV) through high-risk behaviour. We describe anti-HCV Envelope (E) a...

Homelessness among an inpatient HIV-positive cohort at a tertiary care hospital in cent...
https://doi.org/10.1177/0956462420918682
International Journal of STD & AIDS; Sivaraj V, Pittrof R et. al.

May 25th, 2020 - A cohort review was conducted at a central London tertiary care hospital trust on the prevalence of homelessness among human immunodeficiency virus (HIV)-positive inpatients over a year. Data were collected on the duration of inpatient stay, co-mo...

Reinfection following successful direct-acting antiviral therapy for hepatitis C infect...
https://doi.org/10.1093/cid/ciaa253
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America; Cunningham EB, Hajarizadeh B et. al.

Mar 11th, 2020 - The aim of this analysis was to calculate the incidence of HCV reinfection and associated factors among two clinical trials of HCV DAA treatment in people with recent injecting drug use or currently receiving OAT. Participants who achieved an end-...

Outcome of Different Approaches to Reduce Urinary Tract Infection in Patients with Spin...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543607
American Journal of Physical Medicine & Rehabilitation; Chang SC, Zeng S et. al.

Mar 5th, 2020 - Injecting drug use (IDU) is a key driver of the HIV epidemic particularly when individuals experience psychosocial conditions and risky sexual behavior in a syndemic manner. This study sets out to assess evidence of a syndemic pattern of psychosoc...

see more →

Guidelines  4 results

A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis C
https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.2018.05232?journalCode=hlthaff
Powell,D.,et al

Feb 3rd, 2019 - The hepatitis C virus is responsible for more deaths in the United States than any other infectious disease, and hepatitis C infections have been rising at an alarming rate since 2010. We evaluated the role of the opioid epidemic and, in particula...

National Trends in Hospitalizations for Stroke Associated With Infective Endocarditis and Opioid Use Between 1993 and 2015
https://www.ahajournals.org/doi/pdf/10.1161/STROKEAHA.118.024436
Omran,S.,et al

Jan 29th, 2019 - There has been a recent sharp rise in opioid-related deaths in the United States. Intravenous opioid use can lead to infective endocarditis (IE) which can result in stroke. There are scant data on recent trends in this neurological complication of...

Hepatitis C Infection: ASAM Guideline
https://asam.org/advocacy/find-a-policy-statement/view-policy-statement/public-policy-statements/2017/04/11/hepatitis-c
American Society of Addiction Medicine

Apr 4th, 2017 - HCV is primarily transmitted through percutaneous exposure to contaminated blood. Since 1992, the US blood supply has been screened for Hepatitis C, making the risk of transfusion-transmitted HCV extremely rare.

Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug ...
https://stacks.cdc.gov/view/cdc/38856
CDC

Apr 17th, 2016 - The purpose of these guidelines is to provide health care providers in the United States with updated guidelinesto the 2005 U. S.

see more →

Clinicaltrials.gov  551 results

Low hepatitis C virus reinfection rate despite ongoing risk following universal access ...
https://doi.org/10.1097/QAD.0000000000002562
AIDS (London, England); Hosseini-Hooshyar S, Martinello M et. al.

Jun 26th, 2020 - To evaluate changes in injecting and sexual risk behaviours, and hepatitis C virus (HCV) reinfection incidence among people with HIV/HCV coinfection following unrestricted access to direct-acting antiviral therapy in Australia. Prospective observa...

Anti-envelope antibody responses in highly exposed seronegative individuals may be asso...
https://doi.org/10.1111/jvh.13339
Journal of Viral Hepatitis REFERENCES; Mina M, Underwood A et. al.

Jun 4th, 2020 - In rare cases, individuals with a history of long-term injecting drug use remain seronegative and aviraemic, despite prolonged and likely repeated exposure to Hepatitis C virus (HCV) through high-risk behaviour. We describe anti-HCV Envelope (E) a...

Homelessness among an inpatient HIV-positive cohort at a tertiary care hospital in cent...
https://doi.org/10.1177/0956462420918682
International Journal of STD & AIDS; Sivaraj V, Pittrof R et. al.

May 25th, 2020 - A cohort review was conducted at a central London tertiary care hospital trust on the prevalence of homelessness among human immunodeficiency virus (HIV)-positive inpatients over a year. Data were collected on the duration of inpatient stay, co-mo...

Reinfection following successful direct-acting antiviral therapy for hepatitis C infect...
https://doi.org/10.1093/cid/ciaa253
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America; Cunningham EB, Hajarizadeh B et. al.

Mar 11th, 2020 - The aim of this analysis was to calculate the incidence of HCV reinfection and associated factors among two clinical trials of HCV DAA treatment in people with recent injecting drug use or currently receiving OAT. Participants who achieved an end-...

Outcome of Different Approaches to Reduce Urinary Tract Infection in Patients with Spin...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543607
American Journal of Physical Medicine & Rehabilitation; Chang SC, Zeng S et. al.

Mar 5th, 2020 - Injecting drug use (IDU) is a key driver of the HIV epidemic particularly when individuals experience psychosocial conditions and risky sexual behavior in a syndemic manner. This study sets out to assess evidence of a syndemic pattern of psychosoc...

see more →

News  31 results

A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis C
https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.2018.05232?journalCode=hlthaff
Powell,D.,et al

Feb 3rd, 2019 - The hepatitis C virus is responsible for more deaths in the United States than any other infectious disease, and hepatitis C infections have been rising at an alarming rate since 2010. We evaluated the role of the opioid epidemic and, in particula...

National Trends in Hospitalizations for Stroke Associated With Infective Endocarditis and Opioid Use Between 1993 and 2015
https://www.ahajournals.org/doi/pdf/10.1161/STROKEAHA.118.024436
Omran,S.,et al

Jan 29th, 2019 - There has been a recent sharp rise in opioid-related deaths in the United States. Intravenous opioid use can lead to infective endocarditis (IE) which can result in stroke. There are scant data on recent trends in this neurological complication of...

‘Reverse transitions’ from injecting to noninjecting drug use studied
https://www.mdedge.com/familymedicine/article/169460/addiction-medicine/reverse-transitions-injecting-noninjecting-drug-use
MDedge Psychiatry; Doug Brunk

Jul 3rd, 2018 - SAN DIEGO – The transition from noninjecting to injecting drug use can be a reversible process, results from a long-term study suggest. “There’s a common stereotype in popular culture and in academic research that once people start injecting drugs.

Tenofovir Reduces HIV Infections in Injection Drug Users
https://www.medscape.com/viewarticle/805739

Jun 11th, 2013 - Preexposure prophylaxis (PrEP) with tenofovir disoproxil fumarate nearly halved (48.9%) HIV infection rates in injection drug users, according to a randomized, double-blind, placebo-controlled, phase 3 trial of 2413 participants in Thailand. Kachi...

"Harm reduction" needed to cut drug-user AIDS risk
https://www.reuters.com/article/us-aids-harm-reduction/harm-reduction-needed-to-cut-drug-user-aids-risk-idUSTRE63O2C120100425

Apr 25th, 2010 - LONDON (Reuters) - Barely a twentieth of the estimated $3.2 billion needed is put into preventing drug users spreading the AIDS virus, experts said on Monday, and the shortfall is fuelling HIV epidemics in parts of Europe and Asia. In a report on ...

see more →